Haemonetics Corp. (HAE)
57.64
+0.14
(+0.24%)
USD |
NYSE |
Feb 12, 16:00
57.61
-0.03
(-0.05%)
After-Hours: 20:00
Haemonetics EPS Diluted (Quarterly) : 0.9522 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DexCom, Inc. | 0.7035 |
| Celldex Therapeutics, Inc. | -1.009 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.74M |
| Revenue (Quarterly) | 338.97M |
| Total Expenses (Quarterly) | 294.23M |
| Enterprise Value | 3.540B |
| Gross Profit Margin (Quarterly) | 56.47% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 6.31% |
| Operating Earnings Yield | 8.78% |
| Normalized Earnings Yield | 6.327 |